The Ezra Klein Show

Christopher Nolan's Finest Trick | The Ezra Klein Show

Is Trump Running Out of Steam? | The Ezra Klein Show

The Democratic Party Needs Change | The Ezra Klein Show

Platner’s Top Strategist on What Went Wrong | The Ezra Klein Show

What Americans Need to Understand About China | The Ezra Klein Show

The Miracles (and Maddening Politics) of the Clean Energy Revolution | The Ezra Klein Show

A Radical Vision for Israelis and Palestinians | The Ezra Klein Show

Loving America Honestly | The Ezra Klein Show

What Has Chris Rufo Wrought? | The Ezra Klein Show

Gary Shteyngart Warned Us | The Ezra Klein Show

Graham Platner, Jon Ossoff, and the New Rules of Political Attention | The Ezra Klein Show

What’s the Left’s Vision for Foreign Policy After Trump? | The Ezra Klein Show

The Right’s Pre-Modern ‘Masculinist’ Fantasy | The Ezra Klein Show

Ian Bremmer on the Risks America Poses to the World | The Ezra Klein Show

This is How Democrats Could Retake the Senate | The Ezra Klein Show

Yuval Noah Harari on Donald Trump’s Core Delusion | The Ezra Klein Show

Is It Time to Break the Two-Party System? | The Ezra Klein Show

This Is Why I Find Pema Chödrön So Essential | The Ezra Klein Show

Ezra Klein Grills CA’s Possible Governors | The Ezra Klein Show

GLP-1s Are a Lot Weirder Than Anyone Thought | The Ezra Klein Show

GLP-1 receptor agonists have fundamentally altered the landscape of weight management and chronic disease treatment, moving beyond their original diabetes indication to offer significant cardiovascular and anti-inflammatory benefits. These medications function by modulating brain-based hunger signals, effectively silen...